Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,205 INR | -1.40% | +3.16% | +7.02% |
Sales 2024 * | 279B 3.34B | Sales 2025 * | 299B 3.58B | Capitalization | 1,033B 12.37B |
---|---|---|---|---|---|
Net income 2024 * | 54.64B 654M | Net income 2025 * | 56.74B 679M | EV / Sales 2024 * | 3.46 x |
Net cash position 2024 * | 67.94B 814M | Net cash position 2025 * | 107B 1.28B | EV / Sales 2025 * | 3.1 x |
P/E ratio 2024 * |
18.8
x | P/E ratio 2025 * |
18.1
x | Employees | 25,863 |
Yield 2024 * |
0.66% | Yield 2025 * |
0.71% | Free-Float | 91.52% |
Latest transcript on Dr. Reddy's Laboratories Limited
1 day | -1.40% | ||
1 week | +3.16% | ||
Current month | +0.81% | ||
1 month | +0.81% | ||
3 months | +6.18% | ||
6 months | +15.22% | ||
Current year | +7.02% |
Managers | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
Chairman | 56 | 93-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 74 | 07-06-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.02% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 6,205 | -1.40% | 7,153 |
24-04-29 | 6,294 | +0.64% | 11,775 |
24-04-26 | 6,253 | +0.58% | 8,637 |
24-04-25 | 6,217 | +4.47% | 27,972 |
24-04-24 | 5,951 | -0.05% | 6,843 |
Delayed Quote Bombay S.E., April 30, 2024 at 06:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.02% | 12.38B | |
+33.10% | 704B | |
+28.59% | 577B | |
-3.75% | 348B | |
+18.43% | 327B | |
+5.45% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.83% | 147B |
- Stock Market
- Equities
- DRREDDY Stock